Newell, P. Et Al. 2008. MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , (San-Francisco, Costa Rica).

Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Cabellos, L., Lim, K. H., ... Lesmes, P. M.(2008). MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO . 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica

Newell, Philippa Et Al. "MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO," 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 2008

Newell, Philippa Et Al. "MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO." 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , San-Francisco, Costa Rica, 2008

Newell, P. Et Al. (2008) . "MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO." 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , San-Francisco, Costa Rica.

@conferencepaper{conferencepaper, author={Philippa Newell Et Al. }, title={MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO}, congress name={59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases}, city={San-Francisco}, country={Costa Rica}, year={2008}}